Skip to main content
. 2017 Feb 28;108(2):256–266. doi: 10.1111/cas.13126

Table 5.

Four‐groups analysis according to the presence or absence of CDKN2A and receptor tyrosine kinase genetic alterations

Variable Category No. patients No. deaths Hazard ratio for death (95.0% CI) P‐value
CDKN2A/RTK No deletion/No amplification 169 19 Reference
Deletion/No amplification 14 3 2.398 (0.708–8.120) 0.160
No deletion/Amplification 26 7 2.626 (1.103–6.248) 0.029
Deletion/Amplification 11 4 3.517 (1.196–10.34) 0.022